These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

867 related items for PubMed ID: 15494551

  • 1. Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice.
    Ralph RJ, Caine SB.
    J Pharmacol Exp Ther; 2005 Feb; 312(2):733-41. PubMed ID: 15494551
    [Abstract] [Full Text] [Related]

  • 2. Effects of selective dopamine D1-like and D2-like agonists on prepulse inhibition of startle in inbred C3H/HeJ, SPRET/EiJ, and CAST/EiJ mice.
    Ralph RJ, Caine SB.
    Psychopharmacology (Berl); 2007 Apr; 191(3):731-9. PubMed ID: 17019570
    [Abstract] [Full Text] [Related]

  • 3. Effects of dopamine D1 ligands on eye blinking in monkeys: efficacy, antagonism, and D1/D2 interactions.
    Jutkiewicz EM, Bergman J.
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1008-15. PubMed ID: 15292458
    [Abstract] [Full Text] [Related]

  • 4. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S, Bergman J.
    J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
    [Abstract] [Full Text] [Related]

  • 5. Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors.
    Gogos A, Kwek P, Chavez C, van den Buuse M.
    J Pharmacol Exp Ther; 2010 Apr; 333(1):218-27. PubMed ID: 20042529
    [Abstract] [Full Text] [Related]

  • 6. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
    Tidey JW, Bergman J.
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1163-74. PubMed ID: 9618419
    [Abstract] [Full Text] [Related]

  • 7. The paradoxical effects of SKF83959, a novel dopamine D1-like receptor agonist, in the rat acoustic startle reflex paradigm.
    Zhang ZJ, Jiang XL, Zhang SE, Hough CJ, Li H, Chen JG, Zhen XC.
    Neurosci Lett; 1998 Jun; 382(1-2):134-8. PubMed ID: 15911136
    [Abstract] [Full Text] [Related]

  • 8. SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography.
    O'Sullivan GJ, Roth BL, Kinsella A, Waddington JL.
    Eur J Pharmacol; 2004 Feb 23; 486(3):273-80. PubMed ID: 14985049
    [Abstract] [Full Text] [Related]

  • 9. DAD1- and DAD2-like agonist effects on motor activity of C57 mice: differences compared to rats.
    Halberda JP, Middaugh LD, Gard BE, Jackson BP.
    Synapse; 1997 May 23; 26(1):81-92. PubMed ID: 9097408
    [Abstract] [Full Text] [Related]

  • 10. Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens.
    Rouillon C, Abraini JH, David HN.
    Hippocampus; 2007 May 23; 17(11):1028-36. PubMed ID: 17604350
    [Abstract] [Full Text] [Related]

  • 11. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
    Byrnes EM, Bruno JP.
    Dev Psychobiol; 1994 Sep 23; 27(6):409-24. PubMed ID: 8001729
    [Abstract] [Full Text] [Related]

  • 12. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B, Katz JL, Alling K, Acri JB, Witkin JM.
    J Pharmacol Exp Ther; 1997 Oct 23; 283(1):7-15. PubMed ID: 9336302
    [Abstract] [Full Text] [Related]

  • 13. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D, Osborn CV.
    Eur J Pharmacol; 2005 Dec 28; 528(1-3):88-94. PubMed ID: 16324697
    [Abstract] [Full Text] [Related]

  • 14. Psychomotor stimulation by dopamine D₁-like but not D₂-like agonists in most mouse strains.
    Thomsen M, Ralph RJ, Caine SB.
    Exp Clin Psychopharmacol; 2011 Oct 28; 19(5):342-60. PubMed ID: 21843011
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ, Albers LJ, Le H, Creese I.
    J Pharmacol Exp Ther; 1986 Sep 28; 238(3):846-54. PubMed ID: 3018223
    [Abstract] [Full Text] [Related]

  • 17. Do D1/D2 interactions regulate prepulse inhibition in rats?
    Wan FJ, Taaid N, Swerdlow NR.
    Neuropsychopharmacology; 1996 Apr 28; 14(4):265-74. PubMed ID: 8924194
    [Abstract] [Full Text] [Related]

  • 18. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D(1) and D(2) receptor agonists.
    Cauli O, Morelli M.
    Psychopharmacology (Berl); 2002 Jul 28; 162(3):246-54. PubMed ID: 12122482
    [Abstract] [Full Text] [Related]

  • 19. A comparison of the locomotor stimulant effects of D1-like receptor agonists in mice.
    Desai RI, Terry P, Katz JL.
    Pharmacol Biochem Behav; 2005 Aug 28; 81(4):843-8. PubMed ID: 16000217
    [Abstract] [Full Text] [Related]

  • 20. Activation of D1, but not D2 receptors potentiates dizocilpine-mediated disruption of prepulse inhibition of the startle.
    Bortolato M, Aru GN, Fà M, Frau R, Orrù M, Salis P, Casti A, Luckey GC, Mereu G, Gessa GL.
    Neuropsychopharmacology; 2005 Mar 28; 30(3):561-74. PubMed ID: 15328529
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.